74 FR 239 pgs. 66367-66368 - National Cancer Institute; Notice of Closed Meetings
Type: NOTICEVolume: 74Number: 239Pages: 66367 - 66368
FR document: [FR Doc. E9-29812 Filed 12-14-09; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: National Institutes of Health
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is herebygiven of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussionscould disclose confidential trade secrets or commercial property such as patentable material, and personalinformation concerning individuals associated with the grant applications and/or contract proposals, the disclosureof which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis Panel;Education.
Date: January 26, 2010.
Time: 10:30 a.m. to 12 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel Conference Center,Montgomery County Conference Center Facility,5701 Marinelli Road,North Bethesda, MD 20852.
Contact Person: Ilda M. Mckenna, PhD,Scientific Review Administrator,Research Training Review Branch,Division of Extramural Activities,National Cancer Institute,6116 Executive Boulevard, Room 8111,Bethesda, MD 20892,301-496-7481, mckennai@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel;NCI Centers of Cancer Nanotechnology Excellence I.
Date: February 24-26, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center,9751 Washingtonian Boulevard,Gaithersburg, MD 20878.
Contact Person: Michael B. Small, PhD,Scientific Review Officer,Division of Extramural Activities,National Cancer Institute,National Institutes of Health,6116 Executive Blvd., Room 8127,Bethesda, MD 20892-8328,301-402-0996, smallm@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel;NCI Centers of Cancer Nanotechnology Excellence II.
Date: February 24-26, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center,9751 Washingtonian Blvd,Gaithersburg, MD 20878.
Contact Person: Peter J. Wirth, PhD,Scientific Review Officer,Research Programs Review Branch,Division of Extramural Activities,National Cancer Institute,6116 Executive Boulevard, Room 8131,Bethesda, MD 20892-8328,301-496-7565, pw2q@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel;Support for Human Specimen Banking in NCI-Supported Clinical Trials.
Date: March 2, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda,One Bethesda Metro Center,7400 Wisconsin Avenue,Bethesda, MD 20814.
Contact Person: Donald L. Coppock, PhD,Scientific Review Officer,Scientific Review and Logistic Branch,Division of Extramural Activities, NCI,National Institutes of Health,6116 Executive Blvd., Rm. 7151,Bethesda, MD 20892,301-451-9385, donald.coppock@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel;Instruments and Devices for Cancer Diagnosis, Prognosis, and Treatment.
Date: March 16-17, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract proposals.
Place: Bethesda North Marriott Hotel Conference Center,Montgomery County Conference Center Facility,5701 Marinelli Road,North Bethesda, MD 20852.
Contact Person: Adriana Stoica, PhD,Scientific Review Officer,Special Review Logistics Branch,Division of Extramural Activities,National Cancer Institute, NIH,6116 Executive Blvd., Ste. 703, Rm. 7072,Bethesda, MD 20892-8329,301-594-1408, Stoicaa2@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause andPrevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research;93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399,Cancer Control, National Institutes of Health, HHS)
Dated: December 7, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-29812 Filed 12-14-09; 8:45 am]
BILLING CODE 4140-01-P